Skip to content
10-K

Annual Report

Envoy Medical, Inc. COCH COCHW

0001213900-26-032683

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 23.26M sh
Shares Diluted FY 2025 · Dec 31, 2024 18.79M sh
Dividends Paid FY 2025 · Dec 31, 2025 $1.82M
Dividends Paid FY 2025 · Dec 31, 2024 $2.45M
Capex FY 2025 · Dec 31, 2025 $179K
Capex FY 2025 · Dec 31, 2024 $980K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$18.2M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$17.95M
Stockholders Equity FY 2025 · Dec 31, 2025 −$12.16M
Stockholders Equity FY 2025 · Dec 31, 2024 −$18.84M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$1.78M
Current Liabilities FY 2025 · Dec 31, 2025 $11.56M
Current Liabilities FY 2025 · Dec 31, 2024 $7.54M
Total Liabilities FY 2025 · Dec 31, 2025 $20.33M
Total Liabilities FY 2025 · Dec 31, 2024 $30.38M
Current Assets FY 2025 · Dec 31, 2025 $6.28M
Current Assets restated FY 2025 · Dec 31, 2024 $8.9M
Total Assets FY 2025 · Dec 31, 2025 $8.56M
Total Assets FY 2025 · Dec 31, 2024 $11.54M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.23
Eps Diluted FY 2025 · Dec 31, 2024 −$1.49
Eps Basic FY 2025 · Dec 31, 2025 −$1.23
Eps Basic FY 2025 · Dec 31, 2024 −$1.49
Rd Expense FY 2025 · Dec 31, 2025 $12.49M
Rd Expense FY 2025 · Dec 31, 2024 $10.18M
Net Income FY 2025 · Dec 31, 2025 −$23.76M
Net Income FY 2025 · Dec 31, 2024 −$20.8M
Operating Income FY 2025 · Dec 31, 2025 −$22.27M
Operating Income FY 2025 · Dec 31, 2024 −$19.26M
Revenue FY 2025 · Dec 31, 2025 $241K
Revenue FY 2025 · Dec 31, 2024 $225K